The impact of inflammation on hematopoietic stem cell specification

炎症对造血干细胞规范的影响

基本信息

项目摘要

Hematopoietic stem cells (HSCs) are rare cells within human bone marrow that are responsible both for the life-long replenishment of all blood cell lineages and for the curative effects of bone marrow transplantation. The creation of human induced pluripotent stem cells holds great promise for cellular regeneration therapies, but it is not currently possible to instruct these cells to generate HSCs in vitro. The goal of this application is to determine how pro-inflammatory signaling via NF-kB instructs HSC fate in the vertebrate embryo, and how this process is regulated by Progranulin a (Pgrna), with the ultimate goal of replicating HSC generation in vitro for clinical utility. My working hypothesis is that early pro-inflammatory inputs converge to activate NF-kB, which in turn activates key signaling events in the specification of HSC fate. These pro-inflammatory signals need to be downregulated soon after HSC specification; my preliminary results suggest that Pgrna functions in this manner. To test these hypotheses, this proposal consists of 2 aims: (1) Characterize the role of NF-kB in HSC specification; and (2) identify the role of Pgrna in HSC emergence. This study will be conducted in zebrafish, which are an ideal system for direct visualization of HSCs and have served as a model organism to study human disease. To achieve this application’s goals, novel transgenic and mutant lines will be generated, and qPCR, FACS-sorting, RNA-seq and confocal microscopy techniques will be utilized. Dr. Espin Palazon is a postdoctoral fellow in David Traver’s laboratory at UCSD whose ultimate career goal is to lead an independent research group focused on stem cells at a major research institution. Her short- term goals are (1) to determine the spatiotemporal requirements of NF-kB within hemogenic endothelium, and the downstream genes regulated to specify HSCs; and (2) to elucidate how Pgrna governs HSC emergence. She was recruited to join Dr. Traver’s group because of her strong background in immunology and the zebrafish animal model. The project outlined in this proposal will allow Dr. Espin Palazon to transition from a mentored scientific position to an independent research career, helping her gain expertise in FACS sorting, RNA-seq, genome editing techniques, and HSC biology, all of which are fundamental to establish her independent lab. Dr. Espin Palazon will meet and present her work to experts in development, immunology and hematology, in addition to presenting her data to a formal mentorship committee comprised of senior experts that will aid her transition to an independent researcher. UCSD offers numerous courses that Dr. Espin Palazon will attend, as well as seminars on career development and laboratory management. The vibrant, collaborative scientific atmosphere at UCSD is an ideal environment for Dr. Espin Palazon to develop during the mentored phase of her award, and will be instrumental in forming the foundation for the future success of these studies. She is well poised to execute the proposed work, achieve her career development and training goals and to contribute high impact research to the scientific community.
造血干细胞 (HSC) 是人类骨髓中的稀有细胞,负责造血干细胞和造血干细胞 所有血细胞谱系的终生补充以及骨髓移植的疗效。 人类诱导多能干细胞的产生为细胞再生疗法带来了巨大的希望,但是 目前还不可能指导这些细胞在体外生成 HSC。该应用程序的目标是 确定 NF-kB 促炎症信号如何指导脊椎动物胚胎中 HSC 的命运,以及这如何 该过程由颗粒体蛋白前体 a (Pgrna) 调节,最终目标是在体外复制 HSC 生成 临床实用性。我的工作假设是,早期促炎症输入会聚合激活 NF-kB,这在 转激活 HSC 命运规范中的关键信号事件。这些促炎信号需要 HSC 规范后不久下调;我的初步结果表明 Pgrna 以这种方式发挥作用。 为了检验这些假设,该提案包含 2 个目标:(1) 表征 NF-kB 在 HSC 中的作用 规格; (2) 确定 Pgrna 在 HSC 出现中的作用。这项研究将在斑马鱼中进行, 这是直接可视化 HSC 的理想系统,并已作为研究人类的模型生物 疾病。为了实现该应用的目标,将产生新的转基因和突变株系,并进行 qPCR、 将利用 FACS 分选、RNA 测序和共焦显微镜技术。 Espin Palazon 博士是加州大学圣地亚哥分校 David Traver 实验室的博士后研究员,他的最终职业生涯 目标是在一个主要研究机构领导一个专注于干细胞的独立研究小组。她的短篇—— 术语目标是 (1) 确定造血内皮细胞内 NF-kB 的时空需求,以及 下游基因被调节以指定HSC; (2) 阐明 Pgrna 如何控制 HSC 的出现。 由于她在免疫学和斑马鱼方面的深厚背景,她被招募加入 Traver 博士的团队 动物模型。该提案中概述的项目将使 Espin Palazon 博士能够从受指导的人转变为 科学地位转向独立研究职业,帮助她获得 FACS 分选、RNA-seq、 基因组编辑技术和 HSC 生物学,所有这些都是建立她的独立实验室的基础。博士。 Espin Palazon 将在以下地点与发育、免疫学和血液学专家见面并向他们展示她的工作 除了向由高级专家组成的正式指导委员会提供她的数据之外,该委员会将帮助她 转型为独立研究员。加州大学圣地亚哥分校提供 Espin Palazon 博士将参加的众多课程,例如 以及职业发展和实验室管理研讨会。充满活力、协作的科学 UCSD 的氛围是 Espin Palazon 博士在指导阶段发展的理想环境 她的获奖将有助于为这些研究未来的成功奠定基础。她很好 准备好执行拟议的工作,实现职业发展和培训目标,并做出高贡献 对科学界的影响研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raquel Espín Palazón其他文献

Raquel Espín Palazón的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raquel Espín Palazón', 18)}}的其他基金

Molecular dissection of Hematopoietic Stem Cell specification triggered by inflammatory mediators
炎症介质触发造血干细胞规范的分子解剖
  • 批准号:
    10552605
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
Molecular dissection of Hematopoietic Stem Cell specification triggered by inflammatory mediators
炎症介质触发造血干细胞规范的分子解剖
  • 批准号:
    10346708
  • 财政年份:
    2022
  • 资助金额:
    $ 14.65万
  • 项目类别:
In vivo assessment of granulin dependent myeloid cell formation
颗粒蛋白依赖性骨髓细胞形成的体内评估
  • 批准号:
    10201594
  • 财政年份:
    2020
  • 资助金额:
    $ 14.65万
  • 项目类别:
In vivo assessment of granulin dependent myeloid cell formation
颗粒蛋白依赖性骨髓细胞形成的体内评估
  • 批准号:
    10043081
  • 财政年份:
    2020
  • 资助金额:
    $ 14.65万
  • 项目类别:
The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
  • 批准号:
    10475908
  • 财政年份:
    2017
  • 资助金额:
    $ 14.65万
  • 项目类别:
The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
  • 批准号:
    10016274
  • 财政年份:
    2017
  • 资助金额:
    $ 14.65万
  • 项目类别:
The impact of inflammation on hematopoietic stem cell specification
炎症对造血干细胞规范的影响
  • 批准号:
    10242117
  • 财政年份:
    2017
  • 资助金额:
    $ 14.65万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
  • 批准号:
    10601679
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 14.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了